Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes
- PMID: 20421554
- PMCID: PMC2907144
- DOI: 10.1001/archinternmed.2010.57
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes
Abstract
Background: Medicare Part D excludes benzodiazepine medications from coverage, and some state Medicaid programs also limit coverage. We assessed whether such policies decrease the risk of fractures in elderly individuals living in nursing homes.
Methods: This is a quasi-experimental study with interrupted time-series estimation and extended Cox proportional hazards models comparing changes in outcomes before and after implementation of Medicare Part D in a nationwide sample of nursing home residents in 48 states. The study included 1 068 104 residents and a subsample of 50 874 residents with fracture data from 1 pharmacy. We assessed monthly prescribing rates of benzodiazepines and potential substitutes from January 1, 2005, through June 30, 2007, and hazard ratios for incident hip fracture and falls, adjusted for age, sex, and race/ethnicity. Estimates were stratified by concurrent Medicaid limits on benzodiazepines: no supplemental coverage (1 state), partial supplemental coverage (6 states), or complete supplemental coverage (41 states).
Results: The no-supplemental-coverage policy resulted in an immediate and significant reduction of 10 absolute points in benzodiazepine use (27.0% to 17.0%) after Medicare Part D was implemented (95% confidence interval, -0.11 to -0.09; P < .001). Benzodiazepine use remained stable in the partial-supplemental- and complete-supplemental-coverage states. Hazard ratios for incident hip fracture were 1.60 (95% confidence interval, 1.05 to 2.45; P = .03) in the no-supplemental-coverage state after Medicare Part D implementation and 1.17 (95% confidence interval, 0.93 to 1.46; P = .18) in the partial-supplemental-coverage states, relative to complete-supplemental-coverage states.
Conclusion: Supplemental drug coverage exclusion policies affect the medication use of nursing home residents and may not decrease their fracture risk.
Figures
No supplemental coverage
Partial supplemental coverage
Complete supplemental coverage
No supplemental coverage
Partial supplemental coverage
Complete supplemental coverage
Comment in
-
Benzodiazepine use in nursing homes: too much or too little?Arch Intern Med. 2010 Sep 27;170(17):1609; author reply 1609. doi: 10.1001/archinternmed.2010.328. Arch Intern Med. 2010. PMID: 20876418 No abstract available.
Similar articles
-
Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries.JAMA Netw Open. 2020 Apr 1;3(4):e202051. doi: 10.1001/jamanetworkopen.2020.2051. JAMA Netw Open. 2020. PMID: 32242907 Free PMC article.
-
Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates.Ann Intern Med. 2007 Jan 16;146(2):96-103. doi: 10.7326/0003-4819-146-2-200701160-00004. Ann Intern Med. 2007. PMID: 17227933
-
Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders.Psychiatr Serv. 2012 Jul;63(7):637-42. doi: 10.1176/appi.ps.201100331. Psychiatr Serv. 2012. PMID: 22549332 Free PMC article.
-
Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review.Health Serv Res. 2017 Oct;52(5):1685-1728. doi: 10.1111/1475-6773.12534. Epub 2016 Aug 1. Health Serv Res. 2017. PMID: 27480577 Free PMC article. Review.
-
Medicare part D and long-term care: a systematic review of quantitative and qualitative evidence.Drugs Aging. 2013 Sep;30(9):701-20. doi: 10.1007/s40266-013-0096-6. Drugs Aging. 2013. PMID: 23729166 Review.
Cited by
-
Strategies to guide the successful implementation of deprescribing in community practice: Lessons learned from the front line.Can Pharm J (Ott). 2024 May;157(3):133-142. doi: 10.1177/17151635241240737. Epub 2024 Apr 13. Can Pharm J (Ott). 2024. PMID: 38737354 Free PMC article.
-
The balance of prescriptive and dynamic regulatory policies in nursing homes: Lessons learned from the COVID-19 pandemic.J Am Geriatr Soc. 2023 Aug;71(8):2672-2675. doi: 10.1111/jgs.18339. Epub 2023 Mar 23. J Am Geriatr Soc. 2023. PMID: 36959696 Free PMC article. No abstract available.
-
Pharmaceutical policies: effects of regulating drug insurance schemes.Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2. Cochrane Database Syst Rev. 2022. PMID: 35502614 Free PMC article. Review.
-
Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries.JAMA Netw Open. 2020 Apr 1;3(4):e202051. doi: 10.1001/jamanetworkopen.2020.2051. JAMA Netw Open. 2020. PMID: 32242907 Free PMC article.
-
Adequacy of Prescription Drug Coverage in Long-term Care.Med Care. 2020 May;58(5):427-432. doi: 10.1097/MLR.0000000000001291. Med Care. 2020. PMID: 31985585 Free PMC article.
References
-
- Voyery P, Verreault R, Mengue PN, Laurin D, Rochette L, Martin LS. Managing disruptive behaviors with neuroleptics: treatment options for older adults in nursing homes. J Gerontol Nurs. 2005;31:49–59. quiz 60-1. - PubMed
-
- Granek E, Baker SP, Abbey H, et al. Medications and diagnoses in relation to falls in a long-term care facility. J Am Geriatr Soc. 1987;35:503–11. - PubMed
-
- Mustard CA, Mayer T. Case-control study of exposure to medication and the risk of injurious falls requiring hospitalization among nursing home residents. Am J Epidemiol. 1997;145:738–45. - PubMed
-
- Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. Jama. 1989;262:3303–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
